These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 16289708

  • 1. Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virus.
    Ivanovska N, Tchorbanov A, Prechl J, Maximova V, Voynova E, Vassilev TL.
    Vaccine; 2006 Mar 10; 24(11):1830-7. PubMed ID: 16289708
    [Abstract] [Full Text] [Related]

  • 2. The virus-induced signaling adaptor molecule enhances DNA-raised immune protection against H5N1 influenza virus infection in mice.
    Luo M, Qu X, Pan R, Zhu D, Zhang Y, Wu J, Pan Z.
    Vaccine; 2011 Mar 21; 29(14):2561-7. PubMed ID: 21303708
    [Abstract] [Full Text] [Related]

  • 3. Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.
    Smith LR, Wloch MK, Ye M, Reyes LR, Boutsaboualoy S, Dunne CE, Chaplin JA, Rusalov D, Rolland AP, Fisher CL, Al-Ibrahim MS, Kabongo ML, Steigbigel R, Belshe RB, Kitt ER, Chu AH, Moss RB.
    Vaccine; 2010 Mar 16; 28(13):2565-72. PubMed ID: 20117262
    [Abstract] [Full Text] [Related]

  • 4. Studies on antibody responses following neonatal immunization with influenza hemagglutinin DNA or protein.
    Pertmer TM, Robinson HL.
    Virology; 1999 May 10; 257(2):406-14. PubMed ID: 10329551
    [Abstract] [Full Text] [Related]

  • 5. Built-in adjuvanticity of genetically and protein-engineered chimeric molecules for targeting of influenza A peptide epitopes.
    Kerekov NS, Ivanova II, Mihaylova NM, Nikolova M, Prechl J, Tchorbanov AI.
    Immunol Res; 2014 Oct 10; 60(1):23-34. PubMed ID: 24515613
    [Abstract] [Full Text] [Related]

  • 6. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
    Fu TM, Guan L, Friedman A, Schofield TL, Ulmer JB, Liu MA, Donnelly JJ.
    J Immunol; 1999 Apr 01; 162(7):4163-70. PubMed ID: 10201942
    [Abstract] [Full Text] [Related]

  • 7. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D, Christopher ME, Nagata LP, Zabielski MA, Li H, Wong JP, Samuel J.
    J Clin Virol; 2004 Dec 01; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [Abstract] [Full Text] [Related]

  • 8. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P, Luo M, Pan R, Ling D, Zhou S, Tien P, Pan Z.
    Antiviral Res; 2009 Mar 01; 81(3):253-60. PubMed ID: 19135483
    [Abstract] [Full Text] [Related]

  • 9. Long-term maintenance of B cell immunity to influenza virus hemagglutinin in mice following DNA-based immunization.
    Justewicz DM, Webster RG.
    Virology; 1996 Oct 01; 224(1):10-7. PubMed ID: 8862394
    [Abstract] [Full Text] [Related]

  • 10. Immunization with a low dose of hemagglutinin-encoding plasmid protects against 2009 H1N1 pandemic influenza virus in mice.
    Fang J, Chen Z, Liu X, Li H, Wang J, Shen X, Chen W, Liu Y, Wang Y, Zhao P, Qi Z.
    J Virol Methods; 2011 May 01; 173(2):314-9. PubMed ID: 21392537
    [Abstract] [Full Text] [Related]

  • 11. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M, Tao P, Li J, Zhou S, Guo D, Pan Z.
    J Virol Methods; 2008 Dec 01; 154(1-2):121-7. PubMed ID: 18789973
    [Abstract] [Full Text] [Related]

  • 12. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.
    Thomson SA, Sherritt MA, Medveczky J, Elliott SL, Moss DJ, Fernando GJ, Brown LE, Suhrbier A.
    J Immunol; 1998 Feb 15; 160(4):1717-23. PubMed ID: 9469429
    [Abstract] [Full Text] [Related]

  • 13. Evaluating the vaccine potential of an influenza A viral hemagglutinin and matrix double insertion DNA plasmid.
    Xie H, Liu T, Chen H, Huang X, Ye Z.
    Vaccine; 2007 Nov 01; 25(44):7649-55. PubMed ID: 17913307
    [Abstract] [Full Text] [Related]

  • 14. Bystander help within a polyepitope DNA vaccine improves immune responses to influenza antigens.
    Baird M, Wilson R, Young L, Williman J, Young S, Wilson M, Slobbe L, Lockhart E, Buchan G.
    Scand J Immunol; 2004 Oct 01; 60(4):363-71. PubMed ID: 15379861
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
    Breathnach CC, Clark HJ, Clark RC, Olsen CW, Townsend HG, Lunn DP.
    Vaccine; 2006 Feb 20; 24(8):1180-90. PubMed ID: 16194586
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.